Acute exacerbation of idiopathic pulmonary fibrosis: a proposal

被引:0
|
作者
Johannson, Kerri A. [1 ,2 ]
Collard, Harold R. [2 ]
机构
[1] Univ Calgary, Dept Med, Div Respirol, Calgary, AB T2N 2T9, Canada
[2] Univ Calif San Francisco, Dept Med, Div Pulm Crit Care Med Sleep & Allergy, 505 Parnassus Ave,Box 0111, San Francisco, CA 94313 USA
关键词
Idiopathic pulmonary fibrosis; acute exacerbation; interstitial lung disease; definition; diagnosis; management;
D O I
10.1007/s13665-013-0065-x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Acute exacerbation of idiopathic pulmonary fibrosis (IPF) occurs in approximately 10 % of IPF patients annually, and is a leading cause of morbidity and mortality in this disease. Although currently defined as idiopathic acute worsening, acute exacerbation of IPF may in fact have a variety of causes, in particular infection and aspiration. Central to the pathobiology of clinically meaningful events is a diffuse injury to the IPF lung, manifest histopathologically as diffuse alveolar damage, and biologically as accelerated alveolar epithelial cell injury or repair. On the basis of these recent observations, we propose a new conceptual framework for acute exacerbation of IPF that removes the idiopathic requirement and focuses on the pathophysiological mechanism involved.
引用
收藏
页码:233 / 240
页数:8
相关论文
共 50 条
  • [21] Acute Exacerbation of Idiopathic Pulmonary Fibrosis: Who to Treat, How to Treat
    Tejaswini Kulkarni
    Steven R. Duncan
    Current Pulmonology Reports, 2019, 8 : 123 - 130
  • [22] Acute Exacerbation of Idiopathic Pulmonary Fibrosis: Who to Treat, How to Treat
    Kulkarni, Tejaswini
    Duncan, Steven R.
    CURRENT PULMONOLOGY REPORTS, 2019, 8 (04) : 123 - 130
  • [23] Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis
    Enomoto, Noriyuki
    Oyama, Yoshiyuki
    Enomoto, Yasunori
    Mikamo, Masashi
    Karayama, Masato
    Hozumi, Hironao
    Suzuki, Yuzo
    Kono, Masato
    Furuhashi, Kazuki
    Fujisawa, Tomoyuki
    Inui, Naoki
    Nakamura, Yutaro
    Suda, Takafumi
    CLINICAL RESPIRATORY JOURNAL, 2018, 12 (08) : 2378 - 2389
  • [24] Prognostic value of the qSOFA in patients with acute exacerbation of idiopathic pulmonary fibrosis
    Yamazaki, Ryo
    Nishiyama, Osamu
    Yoshikawa, Kazuya
    Tohda, Yuji
    Matsumoto, Hisako
    RESPIRATORY INVESTIGATION, 2023, 61 (03) : 339 - 346
  • [25] Neutrophil-to-Lymphocyte Ratio in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
    Arai, Toru
    Takimoto, Takayuki
    Takeuchi, Naoko
    Minomo, Shojiro
    Kagawa, Tomoko
    Inoue, Yoshikazu
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (23)
  • [26] Predictors of acute exacerbation in biopsy-proven idiopathic pulmonary fibrosis
    Kishaba, Tomoo
    Hozumi, Hironao
    Fujisawa, Tomoyuki
    Nei, Yuichiro
    Enomoto, Noriyuki
    Sugiura, Hiroaki
    Kitani, Masashi
    Suda, Takafumi
    RESPIRATORY INVESTIGATION, 2020, 58 (03) : 177 - 184
  • [27] Exacerbation of idiopathic pulmonary fibrosis
    Avdeev, S. N.
    Gaynitdinova, V. V.
    Merzhoeva, L. M.
    Neklyudova, G., V
    Tsareva, N. A.
    Noraliva, G. S.
    TERAPEVTICHESKII ARKHIV, 2020, 92 (03) : 73 - 77
  • [28] Approach to acute exacerbation of idiopathic pulmonary fibrosis
    Bhatti, Hammad
    Girdhar, Ankur
    Usman, Faisal
    Cury, James
    Bajwa, Abubakr
    ANNALS OF THORACIC MEDICINE, 2013, 8 (02) : 71 - 77
  • [29] Time for Prevention of Idiopathic Pulmonary Fibrosis Exacerbation
    Richeldi, Luca
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2015, 12 : S181 - S185
  • [30] Pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis: A retrospective study
    Furuya, Kenta
    Sakamoto, Susumu
    Shimizu, Hiroshige
    Sekiya, Muneyuki
    Kinoshita, Arisa
    Isshiki, Takuma
    Sugino, Keishi
    Matsumoto, Keiko
    Homma, Sakae
    RESPIRATORY MEDICINE, 2017, 126 : 93 - 99